Pharma Forum Oct. 10, 2024
- Andrew M. Korda, MSHC
- Oct 10, 2024
- 1 min read
Here are the top news stories for October 10, 2024:
Astellas Pharma Expands Cell Therapy Operations to Japan: Astellas is expanding its subsidiary Universal Cells with a new location in Japan, while reducing staff in the U.S. This marks the company's strategic shift to enhance its cell therapy development, aligning with global trends in regenerative medicine.
Korean Pharma Strengthens Ties with Japan at Bio Japan 2024: As part of Asia's largest biopharmaceutical trade show, Korean companies like Samsung Biologics are capitalizing on Japan's pharmaceutical market. The Biosecure Act could drive new opportunities, given rising tensions between the U.S. and China.
AI-Powered Insitro Partners with Eli Lilly for siRNA Therapy: Insitro, an AI-driven biotech company, has partnered with Eli Lilly to accelerate the development of siRNA-based therapies. This collaboration highlights the growing role of AI in drug discovery and precision medicine. FierceBiotech
Illumina Unveils Updated Benchtop Sequencer: Illumina Launched an upgraded version of its benchtop sequencer, featuring streamlined, push-button workflows aimed at making genomic sequencing more accessible for research and diagnostics. FierceBiotech
ShiraTronics Secures $66M neuromodulation Device for migrane: ShiraTronics has raised $66 million to advance its neuromodulation implant for treating chronic migraines, a promising development in non-drug-based therapies for pain management. FierceBiotech
Comments